Sort by
Keyphrases
Clinical Evaluation
100%
Ischemic Stroke
100%
Placebo-controlled
100%
Multi-stemmed
100%
Clinical Trials
33%
Patient's Will
33%
Therapy Treatment
16%
Myocardial Infarction
16%
Functional Outcome
16%
Multipotent
16%
Treatment Group
16%
Magnetic Resonance Imaging
16%
Bone Marrow Cells
16%
Ischemic Events
16%
Dose-escalation Trial
16%
Acute Stroke
16%
Placebo Groups
16%
Imaging Tomography
16%
Computational Imaging
16%
Randomized Double-blind
16%
Neurological Injury
16%
National Institutes of Health Stroke Scale (NIHSS)
16%
Barthel Index
16%
Host Disease
16%
Spleen Size
16%
Modified Rankin Scale
16%
Reparative Therapy
16%
Damage Model
16%
Allogeneic Cell Therapy
16%
Neurorestorative
16%
Scale Index
16%
Medicine and Dentistry
Placebo
100%
Clinical Trial
100%
Apoplexy
100%
Brain Ischemia
100%
Computer Assisted Tomography
20%
Myocardial Infarction
20%
Group Therapy
20%
Magnetic Resonance Imaging
20%
Bone Marrow Cell
20%
Cell Therapy
20%
Single Drug Dose
20%
National Institutes of Health Stroke Scale
20%
Modified Rankin Scale
20%
Host
20%
Barthel Index
20%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Brain Ischemia
100%
Placebo
100%
Heart Infarction
33%
Cerebrovascular Accident
33%
Barthel Index
33%
Rankin Scale
33%
Host
33%